Phenotype-genotype correlations in autosomal dominant retinitis pigmentosa caused by RHO, D190N

Current Eye Research

Volumn 33, Issue 11-12, 2008, Pages 1014-1022

  Tsui, Irena ^a   Chou, Chai Lin ^b   Palmer, Neeco ^b   Lin, Chyuan Sheng ^b   Tsang, Stephen H ^b,c  

^a JULES STEIN EYE INSTITUTE   (United States)

^b New York Presbyterian Hospital   (United States)

^c NONE   (United States)

Author keywords

Autosomal dominant retinitis pigmentosa; Phosphodiesterase; Rhodopsin

Indexed keywords

RHO FACTOR;

ADULT; ALLELE; ARTICLE; AUTOFLUORESCENCE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CELL MIGRATION; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FAMILY HISTORY; GENETIC ANALYSIS; GENOTYPE; HUMAN; MALE; OPHTHALMOSCOPY; PERIMETRY; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; SCHOOL CHILD; VISUAL ACUITY; VISUAL FIELD;

ADOLESCENT; ADULT; ASPARAGINE; ASPARTIC ACID; CHILD; ELECTRORETINOGRAPHY; FLUORESCENCE; FUNDUS OCULI; GENES, DOMINANT; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; RETINAL PIGMENT EPITHELIUM; RETINITIS PIGMENTOSA; RHODOPSIN; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 57649133978     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802484645     Document Type: Article

References (36)

1. Berson EL. Retinitis pigmentosa: The Friedenwald lecture. Invest Ophthal Vis Sci. 1993;34:1655-1676.
2. Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick TH. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol. 1984;97:357-365.
3. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007;125:151-158.
4. Sullivan LS, Bowne SJ, Birch DG, et al. Prevalence of disease-causing mutations in familieswith autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006;47:3052-3064.
5. Tsang SH, Gouras P. Molecular physiology and pathology of the retina. In: Tasman W, Jaeger EA, eds. Duane's Clinical Opthalmology. Chapter 2. Philadelphia: J.B. Lippincott; 1996.
6. Tsang SH, Gouras P. Photoreceptors and photoreceptor dysfunctions. In: Adelman G, Smith B, eds. Encyclopedia of Neuroscience. Amsterdam: Elsevier Science; 2004:1633-1644.
7. Tsang SH, Burns ME, Calvert PD, et al. Role of the target enzyme in deactivation of photoreceptor G protein in vivo. Science 1998;282:117-121.
8. Tsang SH, Woodruff ML, Janisch KM, Cilluffo MC, Farber DB, Fain GL. Removal of phosphorylation sites of gamma subunit of phosphodiesterase 6 alters rod light response. J Physiol. 2006;14:14.
9. Tsang SH, Woodruff ML, Chen CK, et al. GAP-independent termination of photoreceptor light response by excess gamma subunit of the cGMP- phosphodiesterase. J Neurosci. 2006;26:4472-4480.
10. Woodruff ML, Janisch KM, Peshenko IV, Dizhoor AM, Tsang SH, Fain GL. Modulation of phosphodiesterase 6 turn-off during background illumination in mouse rod photoreceptors. J Neurosci. 2008;28:2064-2074.
11. Janz JM, Fay JF, Farrens DL. Stability of dark state rhodopsin is mediated by a conserved ion pair in intradiscal loop E-2. J Biol Chem. 2003;278:16982-16991.
12. Yan EC, Kazmi MA, Ganim Z, et al. Retinal counterion switch in the photoactivation of the G-protein-coupled receptor rhodopsin. Proc Natl Acad Sci USA. 2003;100:9262-9267.
13. Woodruff M, Wang Z, Chung HY, Redmond T, Fain GL, Lem J. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nat Genet. 2003;35:158-164.
14. Lisman J, Fain G. Support for the equivalent light hypothesis for RP. Nat Med. 1995;1:1254-1255.
15. Fain GL, Lisman JE. Light, Ca2+, and photoreceptor death: New evidence for the equivalent- light hypothesis from arrestin knockout mice [In Process Citation]. Invest Ophthalmol Vis Sci. 1999;40:2770-2772.
16. Tsang SH, Vaclavik V, Bird AC, Robson AG, Holder GE. Novel phenotypic and genotypic findings in X-linked retinoschisis. Arch Ophthalmol. 2007;125:259-267.
17. Robson AG, Saihan Z, Jenkins SA, et al. Functional characterization and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol. 2006;90:472-479.
18. Robson AG, Egan C, Holder GE, Bird AC, Fitzke FW. Comparing rod and cone functionwith fundus autofluorescence images in retinitis pigmentosa. Adv Exp Med Biol. 2003;533:41-47.
19. von Ruckmann A, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79:407-412.
20. Marmor M, Holder G, Seeliger M, Yamamoto S. Standard for clinical electroretinography. 2003:www.ISCEV.org.
21. Tsang SH, Woodruff ML, Jun L, et al. Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness. Human Mutation 2007:243-254.
22. Wabbels B, Demmler A, Paunescu K, Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2006;244:36-45.
23. Berson EL, Gouras P, Gunkel RD. Rod responses in retinitis pigmentosa, dominantly inherited. Arch Ophthalmol. 1968;80:355-388.
24. Berson EL. Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect. Trans Am Ophthalmol Soc. 1990;88:355-388.
25. Koenekoop RK, Lopez I, den Hollander AI, Allikmets R, Cremers FP. Genetic testing for retinal dystrophies and dysfunctions: Benefits, dilemmas, and solutions. Clin Experiment Ophthalmol. 2007;35:473-485.
26. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
27. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
28. Kellner U, Renner AB, Tillack H. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/ hydroxychloroquine. Invest Ophthalmol Vis Sci. 2006;47:3531-3538.
29. Fleckenstein M, Charbel Issa P, Fuchs HA, et al. Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry. Eye. 2008.
30. Robson AG, Michaelides M, Saihan Z, et al. Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence: A review and update. Doc Ophthalmol. 2008;116:79-89.
31. Wilson JH, Wensel TG. The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol Neurobiol. 2003;28:149-158.
32. Mendes HF, Van Der Spuy J, Chapple JP, Cheetham ME. Mechanisms of cell death in rhodopsin retinitis pigmentosa: Implications for therapy. Trends Mol Med. 2005;11:177-185.
33. Neidhardt J, Barthelmes D, Farahmand F, Fleischhauer JC, Berger W. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes. Invest Ophthalmol Vis Sci. 2006;47:1630-1635.
34. Oh KT, Oh DM, Weleber RG, et al. Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosa. Br J Ophthalmol. 2004;88:1533-1537.
35. Berson EL. Long-term visual prognoses in patients with retinitis pigmentosa: The Ludwig von Sallmann lecture. Exp Eye Res. 2007;85:7-14.
36. Schuster A, Weisschuh N, Jagle H, et al. Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol. 2005;89:1258-1264.